Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02785848 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Identifying Barriers and Strategies to Support Self-efficacy for Medication Adherence With Text Messaging

StatusCompleted
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial completed
    • Study completion date changed from estimate of Jul 2028 to Sep 2026
    • Eligibility criteria expanded, about 5 words
  2. Study completion date: Jul 2026 to Jul 2028v12
  3. Study completion date: Jul 2024 to Jul 2026v11
  4. Re-verified, no change to tracked fieldsv10
  5. Study completion date: Jul 2022 to Jul 2024v9
Show 7 earlier versionsHide 7 earlier versions
  1. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 50 to confirmed 70
    • Study completion date: May 2022 to Jul 2022
    • Site details revised
    v8
  2. 2 versions Re-verified since Jul 2, 2020, no change to tracked fieldsv6-v7
  3. Primary and study completion dates: May 2021 to May 2022v5
  4. Primary and study completion dates: May 2019 to May 2021v4
  5. Primary and study completion dates: May 2018 to May 2019v3
  6. Primary and study completion dates: May 2017 to May 2018v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The investigators will explore barriers to improving self-efficacy, or the ability to feel in control of their disease, and medication adherence with text messaging through surveys and interviews with adolescents and adults with SCD cared for at the Vanderbilt Meharry Center of Excellence (VMCE) in Sickle Cell Disease (SCD). The investigators will identify preferences to improve and sustain adherence to daily medication through selection of investigator-proposed or patient-generated text messaging strategies. Finally, the investigators will fill in the literature gaps by describing barriers to self-efficacy and medication adherence among adults with SCD as well as adolescents with SCD who are transitioning to adult care.
Trial Details
NCT Number NCT02785848
Lead Sponsor Vanderbilt University
Conditions
(from sponsor)		 Sickle Cell Disease
Related terms Anemia, Sickle Cell
Enrollment 70 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov